Viewing Study NCT02641457

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:00 PM
Ignite Modification Date: 2026-02-25 @ 8:59 PM
Study NCT ID: NCT02641457
Status: COMPLETED
Last Update Posted: 2015-12-29
First Post: 2015-11-26
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Intravitreal Aflibercept or Ranibizumab for Rubeosis Iridis
Sponsor: Instituto de Olhos de Goiania
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Glaucoma View
None Rubeosis Iridis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None rubeosis iridis View
None glaucoma View
None ranibizumab View
None aflibercept View